oculoheel acu pilieni, šķīdums
biologische heilmittel heel gmbh, germany - echinacea, pilocarpus, karotes officinalis, euphrasia - acu pilieni
renaissance triple set. formula 2 (paziņots 2014.) kapsula
laboratorija sovremennogo zdorovja - kapsula
oculoheel acu pilieni, šķīdums
biologische heilmittel heel gmbh, germany - echinacea, pilocarpus, karotes officinalis, euphrasia - acu pilieni
vertimed 24 mg tabletes
medochemie ltd., cyprus - betahistīna dihidrohlorīds - tablete - 24 mg
vertimed 8 mg tabletes
medochemie ltd., cyprus - betahistīna dihidrohlorīds - tablete - 8 mg
vertimed 16 mg tabletes
medochemie ltd., cyprus - betahistīna dihidrohlorīds - tablete - 16 mg
picato
leo laboratories ltd. - ingenol mebutate - keratozes, aktinika - dermatoloģijā lietojamie antiobiotiskie un ķīmiskās par dermatoloģijas izmantot, citas ķīmiskās - picato ir norādīts kā ādas ārstēšanas nav hyperkeratotic, kas nav hipertrofiska aktīniskā keratoze pieaugušajiem.
bortezomib pharmaswiss 3,5 mg pulveris injekciju šķīduma pagatavošanai
pharmaswiss ceska republika s.r.o., czech republic - bortezomibs - pulveris injekciju šķīduma pagatavošanai - 3,5 mg
bortezomib teva 3,5 mg pulveris injekciju šķīduma pagatavošanai
teva b.v., netherlands - bortezomibs - pulveris injekciju šķīduma pagatavošanai - 3,5 mg
brukinsa
beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastiski līdzekļi - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).